|
|
|
|
|
by irthomasthomas
1139 days ago
|
|
Metformin. Research in humans suggests that metformin can impact mortality. A meta-analysis published in 2017 that included 53 different studies concluded that metformin reduces all-cause mortality and diseases of aging, independent of its effect on diabetes. Also, combinations of Metformin, rapamycin and resveratrol, and NMNs. Davis Sinclaire is probably the leading expert on those, now. He is professor of genetics at Harvard. https://youtube.com/watch?v=bRWT7hVgwuM |
|
> A number of studies assessing adherence to diabetes medications in patients with type 2 diabetes have reported that metformin has the lowest adherence rates when compared with other OAAs.